Monthly Archives: October 2021
News
U.S. FDA approves Vertex’s JOURNAVX for adults with moderate-to-severe acute pain
The U.S. Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals' JOURNAVX (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the...
European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in...
The European Commission has authorised ViiV Healthcare's Vocabria (cabotegravir long-acting injections) in combination with Johnson & Johnson’s Rekambys (rilpivirine long-acting injections) for the treatment of HIV-1 infection in...
U.S. FDA approves Celltrion’s AVTOZMA, a biosimilar to ACTEMRA
The U.S. Food and Drug Administration (FDA) has approved Celltrion's AVTOZMA (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutaneous (SC) formulation as a...
